Details of the Drug Combinations

General Information of This Drug (ID: DMPAZHC)

• Drug Name: Cabazitaxel (DMPAZHC)
• Synonyms: Jevtana; Taxoid XRP6258; Jevtana (TN)

Indication

Breast cancer; ICD 11: 2C60-2C65; Status: Approved [1]; Solid tumour/cancer; ICD 11: 2A00-2F9Z; Status: Phase 2 [1]; Metastatic prostate carcinoma; ICD 11: N.A.; Status: Investigative [2]

• Drug Type: Small molecular drug

List of Combinatorial Drugs (CBD) Containing This Drug

1194 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
ABIRATERONE + Cabazitaxel	DCJ0WAD	ABIRATERONE	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
ABIRATERONE + Cabazitaxel	DCP4TN0	ABIRATERONE	Astrocytoma (Cell Line: U251)	[3]
ABIRATERONE + Cabazitaxel	DC159T4	ABIRATERONE	Astrocytoma (Cell Line: SNB-19)	[3]
ABIRATERONE + Cabazitaxel	DCJJ1OH	ABIRATERONE	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
ABIRATERONE + Cabazitaxel	DC2WGZL	ABIRATERONE	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
ABIRATERONE + Cabazitaxel	DCNUQHC	ABIRATERONE	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
ABIRATERONE + Cabazitaxel	DCY8ZRB	ABIRATERONE	Glioma (Cell Line: SF-268)	[3]
ABIRATERONE + Cabazitaxel	DCZ8LDN	ABIRATERONE	Glioma (Cell Line: SF-539)	[3]
ABIRATERONE + Cabazitaxel	DC0RMWZ	ABIRATERONE	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
ABIRATERONE + Cabazitaxel	DCFKCXX	ABIRATERONE	Carcinoma (Cell Line: MCF7)	[4]
ABIRATERONE + Cabazitaxel	DCX8C1Z	ABIRATERONE	Adenocarcinoma (Cell Line: OVCAR3)	[5]
ABIRATERONE + Cabazitaxel	DC51U2B	ABIRATERONE	Adenocarcinoma (Cell Line: A549)	[5]
ABIRATERONE + Cabazitaxel	DCXP0I1	ABIRATERONE	Adenocarcinoma (Cell Line: NCIH23)	[5]
ABIRATERONE + Cabazitaxel	DC00OAE	ABIRATERONE	Adenocarcinoma (Cell Line: HCT-15)	[5]
ABIRATERONE + Cabazitaxel	DCO9NVH	ABIRATERONE	Adenocarcinoma (Cell Line: HCC-2998)	[5]
ABIRATERONE + Cabazitaxel	DCPUG5X	ABIRATERONE	Adenocarcinoma (Cell Line: HCT116)	[5]
ABIRATERONE + Cabazitaxel	DC5CI13	ABIRATERONE	Adenocarcinoma (Cell Line: HT29)	[5]
ABIRATERONE + Cabazitaxel	DCG7RRX	ABIRATERONE	Adenocarcinoma (Cell Line: SW-620)	[5]
ABIRATERONE + Cabazitaxel	DCZZYID	ABIRATERONE	Amelanotic melanoma (Cell Line: MDA-MB-435)	[5]
ABIRATERONE + Cabazitaxel	DCV9CDH	ABIRATERONE	Amelanotic melanoma (Cell Line: M14)	[5]
ABIRATERONE + Cabazitaxel	DCC2JR4	ABIRATERONE	Cutaneous melanoma (Cell Line: SK-MEL-28)	[5]
ABIRATERONE + Cabazitaxel	DC1FWX5	ABIRATERONE	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[5]
ABIRATERONE + Cabazitaxel	DCCGPJR	ABIRATERONE	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[5]
ABIRATERONE + Cabazitaxel	DCUWW58	ABIRATERONE	Lung adenocarcinoma (Cell Line: HOP-62)	[5]
ABIRATERONE + Cabazitaxel	DCC54ZT	ABIRATERONE	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[5]
ABIRATERONE + Cabazitaxel	DC0QPLD	ABIRATERONE	Malignant melanoma (Cell Line: LOX IMVI)	[5]
ABIRATERONE + Cabazitaxel	DCJUU05	ABIRATERONE	Melanoma (Cell Line: MALME-3M)	[5]
ABIRATERONE + Cabazitaxel	DCP2OCJ	ABIRATERONE	Melanoma (Cell Line: UACC-257)	[5]
ABIRATERONE + Cabazitaxel	DC4YO2T	ABIRATERONE	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[5]
Cabazitaxel + Mechlorethamine	DCT13C4	Mechlorethamine	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Mechlorethamine	DC0CI34	Mechlorethamine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Mechlorethamine	DCMJCEP	Mechlorethamine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Mechlorethamine	DCTGFVJ	Mechlorethamine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Mechlorethamine	DC4W2HW	Mechlorethamine	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Mechlorethamine	DC8RETM	Mechlorethamine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Mechlorethamine	DCIGWFK	Mechlorethamine	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Pentostatin	DC9IVOT	Pentostatin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Pentostatin	DC74TNP	Pentostatin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Pentostatin	DCEPKT6	Pentostatin	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Picoplatin	DCJ01ZQ	Picoplatin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Picoplatin	DCXOE2O	Picoplatin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Fulvestrant	DCCWDJR	Fulvestrant	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Fulvestrant	DC280G1	Fulvestrant	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Fulvestrant	DCBX5ZE	Fulvestrant	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Fulvestrant	DCFW7CZ	Fulvestrant	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Fulvestrant	DC2X3L3	Fulvestrant	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Fulvestrant	DC8DEQC	Fulvestrant	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Fulvestrant	DCWORKV	Fulvestrant	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Fulvestrant	DCM13HU	Fulvestrant	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Fulvestrant	DC8SHRR	Fulvestrant	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Gefitinib	DCKHZGJ	Gefitinib	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Gefitinib	DC30V72	Gefitinib	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Gefitinib	DC86YJI	Gefitinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Gefitinib	DCFVIAF	Gefitinib	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Gefitinib	DCOK524	Gefitinib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Gefitinib	DC0YRQU	Gefitinib	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Gefitinib	DCB92KF	Gefitinib	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Gefitinib	DCTGL4Q	Gefitinib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Gefitinib	DCROFEW	Gefitinib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Gefitinib	DCN6MEI	Gefitinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Gefitinib	DCTDBH9	Gefitinib	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Gefitinib	DCJMZUT	Gefitinib	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Gefitinib	DC327BD	Gefitinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Gefitinib	DCPN0LU	Gefitinib	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Gefitinib	DCO6BWJ	Gefitinib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Gefitinib	DCU2FIQ	Gefitinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Gefitinib	DCXM38D	Gefitinib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Gefitinib	DC3HVH3	Gefitinib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Gefitinib	DC7S5DW	Gefitinib	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Gefitinib	DC4E4H2	Gefitinib	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Gefitinib	DCJDR8G	Gefitinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Gefitinib	DC4MND6	Gefitinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Gefitinib	DCWYNPL	Gefitinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Gefitinib	DCHEX9B	Gefitinib	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Gefitinib	DCE6M9D	Gefitinib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Gefitinib	DCQ3OAC	Gefitinib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Gefitinib	DCLS0QG	Gefitinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Gefitinib	DCCD0AB	Gefitinib	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Gefitinib	DCF8UHR	Gefitinib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Gefitinib	DCKJBGE	Gefitinib	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Gefitinib	DCOX7XU	Gefitinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Gefitinib	DCPT5IJ	Gefitinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Gefitinib	DCD033Y	Gefitinib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Gefitinib	DCZXY97	Gefitinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Gefitinib	DCSZTUH	Gefitinib	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Gefitinib	DCUY2SR	Gefitinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Gefitinib	DCO46O5	Gefitinib	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Gefitinib	DCWROO8	Gefitinib	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Gefitinib	DC5X2R8	Gefitinib	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Ruxolitinib	DC605WF	Ruxolitinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Ruxolitinib	DCB0TLB	Ruxolitinib	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Ruxolitinib	DCPXRYO	Ruxolitinib	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Ruxolitinib	DCW5E20	Ruxolitinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Ruxolitinib	DCRKI87	Ruxolitinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Ruxolitinib	DC3YHCX	Ruxolitinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Ruxolitinib	DCUMT7L	Ruxolitinib	Hodgkin lymphoma (Cell Line: L-1236)	[3]
Cabazitaxel + Ruxolitinib	DC5PJAZ	Ruxolitinib	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Ruxolitinib	DCO0QCI	Ruxolitinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Hepzato	DCH821U	Hepzato	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Hepzato	DC9TEAV	Hepzato	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Hepzato	DCLCGKE	Hepzato	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Hepzato	DC6H9ME	Hepzato	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Hepzato	DCXH4PZ	Hepzato	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Ixabepilone	DC5O2TG	Ixabepilone	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Ixabepilone	DCNWZTX	Ixabepilone	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Ixabepilone	DCFGI2B	Ixabepilone	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Ixabepilone	DC3JPVI	Ixabepilone	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Ixabepilone	DC1W8QH	Ixabepilone	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Ixabepilone	DCKEMOW	Ixabepilone	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Ixabepilone	DC6AC0I	Ixabepilone	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Ixabepilone	DCX0JNZ	Ixabepilone	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Ixabepilone	DCMEB6E	Ixabepilone	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Ixabepilone	DCYMFL1	Ixabepilone	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Ixabepilone	DC1TR7U	Ixabepilone	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Ixabepilone	DCN2XVL	Ixabepilone	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Ixabepilone	DCCUZWU	Ixabepilone	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Ixabepilone	DCYID9A	Ixabepilone	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Ixabepilone	DCMVSV5	Ixabepilone	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Ixabepilone	DC173SU	Ixabepilone	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + Ixabepilone	DCL99S5	Ixabepilone	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Ixabepilone	DCC5NPP	Ixabepilone	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Ixabepilone	DCZZBOF	Ixabepilone	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Dactinomycin	DCZDFKK	Dactinomycin	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Dactinomycin	DCXI5TR	Dactinomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Dactinomycin	DCM9BZD	Dactinomycin	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Dactinomycin	DCDSE0O	Dactinomycin	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Dactinomycin	DC7SJIN	Dactinomycin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Dactinomycin	DCGJT76	Dactinomycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Dactinomycin	DCOOWNM	Dactinomycin	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Dactinomycin	DC5PF2D	Dactinomycin	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Dactinomycin	DCIMCFB	Dactinomycin	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Dactinomycin	DCOICG6	Dactinomycin	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Dactinomycin	DCW7OYQ	Dactinomycin	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + DFN-15	DCO795J	DFN-15	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + DFN-15	DCTHQRR	DFN-15	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + DFN-15	DCERJ69	DFN-15	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + DFN-15	DCHTZYT	DFN-15	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + DFN-15	DCDC5CJ	DFN-15	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + DFN-15	DCLZ1K8	DFN-15	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + DFN-15	DC48JTS	DFN-15	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + DFN-15	DC8H964	DFN-15	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + DFN-15	DC9IW87	DFN-15	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + DFN-15	DCSRCL3	DFN-15	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + DFN-15	DCFZ89L	DFN-15	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Lapatinib	DCTDX8U	Lapatinib	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Lapatinib	DC5UDAO	Lapatinib	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Lapatinib	DCSWUFZ	Lapatinib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Lapatinib	DC6EHCP	Lapatinib	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Lapatinib	DCGN32T	Lapatinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Lapatinib	DCECAA8	Lapatinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Lapatinib	DCPME1X	Lapatinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Lapatinib	DCRRBHJ	Lapatinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Lapatinib	DCY944Q	Lapatinib	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Lapatinib	DC3849A	Lapatinib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Lapatinib	DCQ0XX1	Lapatinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Lapatinib	DCU1XW9	Lapatinib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + PMID28460551-Compound-2	DC02HGE	PMID28460551-Compound-2	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + PMID28460551-Compound-2	DC1DNH4	PMID28460551-Compound-2	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCUZN79	PMID28460551-Compound-2	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCXACSQ	PMID28460551-Compound-2	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + PMID28460551-Compound-2	DC31BUH	PMID28460551-Compound-2	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCHCC3J	PMID28460551-Compound-2	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCK5B70	PMID28460551-Compound-2	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCC609W	PMID28460551-Compound-2	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCQUGGX	PMID28460551-Compound-2	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCF0C0V	PMID28460551-Compound-2	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + PMID28460551-Compound-2	DC3QM3J	PMID28460551-Compound-2	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + PMID28460551-Compound-2	DCKNW2V	PMID28460551-Compound-2	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Crizotinib	DCW36EH	Crizotinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Crizotinib	DC6OC5M	Crizotinib	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Crizotinib	DCBMHKB	Crizotinib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Crizotinib	DCWECVX	Crizotinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Crizotinib	DC1NQG7	Crizotinib	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Crizotinib	DCQADUF	Crizotinib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Crizotinib	DCUA0PN	Crizotinib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Crizotinib	DCS5I94	Crizotinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Crizotinib	DCKZGK6	Crizotinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + LIAROZOLE	DC5M76W	LIAROZOLE	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + LIAROZOLE	DCSTVG0	LIAROZOLE	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + LIAROZOLE	DC10VW1	LIAROZOLE	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + LIAROZOLE	DCRUFQA	LIAROZOLE	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Panobinostat	DC6YIF5	Panobinostat	Diffuse intrinsic pontine glioma (Cell Line: DIPG25)	[3]
Cabazitaxel + Methotrexate	DCKENNP	Methotrexate	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Vismodegib	DC7EYU0	Vismodegib	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Vismodegib	DCXFYVZ	Vismodegib	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Vismodegib	DCY09N0	Vismodegib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Vismodegib	DCZS6E1	Vismodegib	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Vismodegib	DCXXRIC	Vismodegib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Vismodegib	DCOMWT7	Vismodegib	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Vismodegib	DCDDFED	Vismodegib	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Vismodegib	DCEOTGQ	Vismodegib	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Vismodegib	DCQ6C0N	Vismodegib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Vismodegib	DCNNFDS	Vismodegib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Vismodegib	DCVSYOE	Vismodegib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Vismodegib	DC6G64I	Vismodegib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Vismodegib	DCG4NBR	Vismodegib	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Vismodegib	DCFZ3PE	Vismodegib	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Vismodegib	DCARCNE	Vismodegib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Vismodegib	DCKE7NB	Vismodegib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Vismodegib	DC3X3FN	Vismodegib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Vismodegib	DCVGN0R	Vismodegib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Vismodegib	DC2SRV3	Vismodegib	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Vismodegib	DC8KGGP	Vismodegib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Vismodegib	DCTSA5B	Vismodegib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Vismodegib	DC401DI	Vismodegib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Vismodegib	DCFPYI1	Vismodegib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Vismodegib	DCBO1VG	Vismodegib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Vismodegib	DC2F728	Vismodegib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Vemurafenib	DC9AQM3	Vemurafenib	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + Vemurafenib	DCV59G5	Vemurafenib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Vemurafenib	DC4F363	Vemurafenib	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Vemurafenib	DC7T4IF	Vemurafenib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Vemurafenib	DC4PG0D	Vemurafenib	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + Vemurafenib	DC8KBM5	Vemurafenib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Vemurafenib	DCSZOBO	Vemurafenib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Vemurafenib	DCHWQ8Q	Vemurafenib	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Lenalidomide	DCSXHMV	Lenalidomide	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Lenalidomide	DCZFRF4	Lenalidomide	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Lenalidomide	DCI6H51	Lenalidomide	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Lenalidomide	DCA18F5	Lenalidomide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Lenalidomide	DCM369C	Lenalidomide	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Lenalidomide	DCEJIQP	Lenalidomide	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Lenalidomide	DC1Z5DE	Lenalidomide	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Plicamycin	DC6MA2T	Plicamycin	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Plicamycin	DCFKIO7	Plicamycin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Plicamycin	DCW4KUL	Plicamycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Plicamycin	DC7912S	Plicamycin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Plicamycin	DCBSFP9	Plicamycin	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Plicamycin	DCARKRK	Plicamycin	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Plicamycin	DCQLT1P	Plicamycin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Plicamycin	DC3APSN	Plicamycin	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Plicamycin	DC88NCY	Plicamycin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Plicamycin	DCRN3ZN	Plicamycin	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Plicamycin	DCZ6FN5	Plicamycin	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Plicamycin	DCZHY12	Plicamycin	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Plicamycin	DCD4UUV	Plicamycin	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Plicamycin	DCY037T	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Plicamycin	DCQ2IHU	Plicamycin	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Plicamycin	DC747PX	Plicamycin	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Plicamycin	DCXXD9Y	Plicamycin	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Plicamycin	DCBS5KM	Plicamycin	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Plicamycin	DC4GTW3	Plicamycin	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Nilotinib	DCWODH9	Nilotinib	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Nilotinib	DCJ6DE5	Nilotinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Nilotinib	DC6J9WO	Nilotinib	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Nilotinib	DCZCXNY	Nilotinib	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Nilotinib	DC5KNCW	Nilotinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Nilotinib	DC07HF0	Nilotinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Nilotinib	DCOWUA5	Nilotinib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Thioguanine	DCJ3WTV	Thioguanine	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Thioguanine	DC7YHGP	Thioguanine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Thioguanine	DCXAA9Z	Thioguanine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Thioguanine	DCK7OSQ	Thioguanine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Thioguanine	DCWTKGK	Thioguanine	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Thioguanine	DCDU9B9	Thioguanine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Thioguanine	DCSMQXN	Thioguanine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Thioguanine	DCELTPN	Thioguanine	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Thioguanine	DCRMT68	Thioguanine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Thioguanine	DC988GF	Thioguanine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Thioguanine	DC3QTF6	Thioguanine	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Thioguanine	DC2635Q	Thioguanine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Thioguanine	DCDW7QO	Thioguanine	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Thioguanine	DCMSYKF	Thioguanine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + ABIRATERONE	DCYIDLH	ABIRATERONE	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + ABIRATERONE	DCCB8NU	ABIRATERONE	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + ABIRATERONE	DCZXGLB	ABIRATERONE	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + ABIRATERONE	DCT200A	ABIRATERONE	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + ABIRATERONE	DCXPVJO	ABIRATERONE	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + ABIRATERONE	DCAZSGX	ABIRATERONE	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + ABIRATERONE	DCXQMN5	ABIRATERONE	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + ABIRATERONE	DCDZAKB	ABIRATERONE	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + ABIRATERONE	DC6ZX9I	ABIRATERONE	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + ABIRATERONE	DCCI7CX	ABIRATERONE	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + ABIRATERONE	DCJPYCN	ABIRATERONE	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + ABIRATERONE	DC4RJLS	ABIRATERONE	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + ABIRATERONE	DCI3O6Z	ABIRATERONE	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + ABIRATERONE	DCPLFKR	ABIRATERONE	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + ABIRATERONE	DCFEPRS	ABIRATERONE	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + ABIRATERONE	DCH95OO	ABIRATERONE	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + ABIRATERONE	DCDP000	ABIRATERONE	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + ABIRATERONE	DCMEVCL	ABIRATERONE	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + ABIRATERONE	DCPYRRY	ABIRATERONE	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + ABIRATERONE	DCC013U	ABIRATERONE	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + ABIRATERONE	DCDXLIA	ABIRATERONE	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DC5XS5B	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCTAA5X	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCW15IV	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCKG46N	10-hydroxycamptothecin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DC0C947	10-hydroxycamptothecin	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCKRGA9	10-hydroxycamptothecin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DC30GP6	10-hydroxycamptothecin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCDTFRE	10-hydroxycamptothecin	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCLZGGK	10-hydroxycamptothecin	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCQDJGG	10-hydroxycamptothecin	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCXVXTY	10-hydroxycamptothecin	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DC9WA37	10-hydroxycamptothecin	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCYQGNQ	10-hydroxycamptothecin	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DCWLN41	10-hydroxycamptothecin	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + 10-hydroxycamptothecin	DC9OV79	10-hydroxycamptothecin	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Topetecan	DCYKXXX	Topetecan	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Topetecan	DCF4972	Topetecan	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Topetecan	DCTY7V8	Topetecan	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Topetecan	DCJMA1J	Topetecan	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Topetecan	DCLAEHA	Topetecan	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Topetecan	DCL6TTJ	Topetecan	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + Topetecan	DCO7LU5	Topetecan	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Amonafide	DCUMU0C	Amonafide	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Amonafide	DC31FLC	Amonafide	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Amonafide	DCKR0NL	Amonafide	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Amonafide	DCCC10S	Amonafide	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Amonafide	DC3M20K	Amonafide	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Amonafide	DCVS3YN	Amonafide	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Amonafide	DCSKOG9	Amonafide	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Amonafide	DC3OAP6	Amonafide	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Amonafide	DCRV97B	Amonafide	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Amonafide	DCANWID	Amonafide	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Pralatrexate	DC2AR02	Pralatrexate	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Pralatrexate	DC1TA7I	Pralatrexate	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Pralatrexate	DCEBD3A	Pralatrexate	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Pralatrexate	DC1ZUQH	Pralatrexate	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Pralatrexate	DC7HSAP	Pralatrexate	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + Pralatrexate	DC1KX21	Pralatrexate	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Pralatrexate	DCMB0K3	Pralatrexate	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Pralatrexate	DCPVYO7	Pralatrexate	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Pralatrexate	DCW1L3K	Pralatrexate	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Pralatrexate	DC0WX4Q	Pralatrexate	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Pralatrexate	DCOX79X	Pralatrexate	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Pralatrexate	DC61SXM	Pralatrexate	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Pralatrexate	DCNJXT8	Pralatrexate	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Pralatrexate	DC4EP2I	Pralatrexate	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Pralatrexate	DC8WWHF	Pralatrexate	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Pralatrexate	DCR42AQ	Pralatrexate	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Pralatrexate	DCXXU90	Pralatrexate	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Pralatrexate	DCFZOG2	Pralatrexate	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Pralatrexate	DCZTP9V	Pralatrexate	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Pralatrexate	DCTOH5Z	Pralatrexate	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Pralatrexate	DCAHHXF	Pralatrexate	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Pralatrexate	DC5O6S6	Pralatrexate	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Terameprocol	DCEQQV9	Terameprocol	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + SCH 727965	DC9S5J7	SCH 727965	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + SCH 727965	DCP8EM8	SCH 727965	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Ifosfamide	DCA2YYS	Ifosfamide	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Dexrazoxane	DCDT8JH	Dexrazoxane	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Dexrazoxane	DCEMBQU	Dexrazoxane	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Dexrazoxane	DCEAC0O	Dexrazoxane	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Dexrazoxane	DCJNYGO	Dexrazoxane	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Dexrazoxane	DCFWOVY	Dexrazoxane	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Dexrazoxane	DCISSO8	Dexrazoxane	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Dexrazoxane	DCB64JO	Dexrazoxane	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Dexrazoxane	DCQ0GGU	Dexrazoxane	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Dexrazoxane	DCYWEDP	Dexrazoxane	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Dexrazoxane	DCPL8P6	Dexrazoxane	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Dexrazoxane	DCGYIK6	Dexrazoxane	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Docetaxel	DCJDSYU	Docetaxel	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Docetaxel	DCZIZDJ	Docetaxel	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Docetaxel	DCQXF0G	Docetaxel	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Docetaxel	DCA23MJ	Docetaxel	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Docetaxel	DC5WZCS	Docetaxel	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Docetaxel	DC0WZ2D	Docetaxel	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Docetaxel	DC9DP82	Docetaxel	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Docetaxel	DC87ETI	Docetaxel	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Docetaxel	DCIR09L	Docetaxel	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Docetaxel	DCDEMGQ	Docetaxel	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Docetaxel	DCHVO1P	Docetaxel	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Docetaxel	DC5GN0I	Docetaxel	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Docetaxel	DCACUDZ	Docetaxel	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Docetaxel	DCHB6J6	Docetaxel	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Docetaxel	DCE3EJZ	Docetaxel	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Docetaxel	DCJAM65	Docetaxel	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Docetaxel	DCVKQNG	Docetaxel	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Docetaxel	DC2BLMT	Docetaxel	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Docetaxel	DC7XYES	Docetaxel	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Docetaxel	DC1P6X8	Docetaxel	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Docetaxel	DCK61IS	Docetaxel	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Docetaxel	DCPD55X	Docetaxel	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Docetaxel	DCUYWDR	Docetaxel	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Docetaxel	DCPPG61	Docetaxel	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Docetaxel	DC7M91U	Docetaxel	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Docetaxel	DCMD64H	Docetaxel	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Raloxifene	DCH2D3K	Raloxifene	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Raloxifene	DC0U27L	Raloxifene	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Raloxifene	DC2V581	Raloxifene	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Raloxifene	DCQP20D	Raloxifene	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Bendamustine hydrochloride	DC2NGKO	Bendamustine hydrochloride	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + Bendamustine hydrochloride	DC8SHCN	Bendamustine hydrochloride	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Bendamustine hydrochloride	DC3L6TL	Bendamustine hydrochloride	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Bendamustine hydrochloride	DCE1DZK	Bendamustine hydrochloride	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Bendamustine hydrochloride	DCDINHQ	Bendamustine hydrochloride	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Bendamustine hydrochloride	DCMRLFA	Bendamustine hydrochloride	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Bendamustine hydrochloride	DCHXMTO	Bendamustine hydrochloride	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Bendamustine hydrochloride	DCOM78A	Bendamustine hydrochloride	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Trifluridine	DCN331L	Trifluridine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Trifluridine	DCS6Y18	Trifluridine	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Trifluridine	DC6A9S5	Trifluridine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Trifluridine	DCYZQP6	Trifluridine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Trifluridine	DCS9JV2	Trifluridine	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Trifluridine	DC53PNM	Trifluridine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Trifluridine	DCBOB6N	Trifluridine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Trifluridine	DCJKPGS	Trifluridine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Trifluridine	DCSPITM	Trifluridine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Trifluridine	DC5KG9S	Trifluridine	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Trifluridine	DCQ7V9R	Trifluridine	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Trifluridine	DC1PW5R	Trifluridine	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Trifluridine	DCOMNFG	Trifluridine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Sirolimus	DC0THID	Sirolimus	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Sirolimus	DCP73KR	Sirolimus	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Sirolimus	DCQLNK0	Sirolimus	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Sirolimus	DCNIOBO	Sirolimus	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Sirolimus	DCAJVX3	Sirolimus	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Sirolimus	DC6C03Q	Sirolimus	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Sirolimus	DC4K83U	Sirolimus	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Sirolimus	DCVCLH7	Sirolimus	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Sirolimus	DCMHW3R	Sirolimus	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Sirolimus	DC3V8NQ	Sirolimus	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Sirolimus	DCBG2ZH	Sirolimus	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Sirolimus	DC25YED	Sirolimus	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Sirolimus	DCPLH16	Sirolimus	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Sirolimus	DCJ1VVO	Sirolimus	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Sirolimus	DCDWMOT	Sirolimus	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Sirolimus	DCHS59M	Sirolimus	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Sirolimus	DCDEOE4	Sirolimus	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Sirolimus	DC30CXZ	Sirolimus	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Sirolimus	DC33X8K	Sirolimus	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Sirolimus	DCG2KYM	Sirolimus	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Sirolimus	DCC9FTL	Sirolimus	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Sirolimus	DCWQ0Y2	Sirolimus	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Sirolimus	DC3SRH1	Sirolimus	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Sirolimus	DCK7A1Y	Sirolimus	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Sirolimus	DCDAQNU	Sirolimus	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Sirolimus	DCPAUWH	Sirolimus	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + Sirolimus	DCEUVHD	Sirolimus	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Sirolimus	DC5M5MZ	Sirolimus	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Sirolimus	DCJMFP4	Sirolimus	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Sirolimus	DC3CG3E	Sirolimus	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Sirolimus	DCX1O4W	Sirolimus	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Sirolimus	DCZMPRB	Sirolimus	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Sirolimus	DCT4T79	Sirolimus	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Sirolimus	DCHR28Y	Sirolimus	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Sirolimus	DCAFFM9	Sirolimus	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Sirolimus	DCDKG0V	Sirolimus	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Mitomycin	DCT2D84	Mitomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Mitomycin	DCF4NFI	Mitomycin	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Mitomycin	DCSCYO7	Mitomycin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Mitomycin	DCS00R7	Mitomycin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Mitomycin	DCZLWF6	Mitomycin	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Mitomycin	DCHJQGN	Mitomycin	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Mitomycin	DC1S6LQ	Mitomycin	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Mitomycin	DC7YPMU	Mitomycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Mitomycin	DC1GOC3	Mitomycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Mitomycin	DCC6ACS	Mitomycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + SY-1425	DCX1XS1	SY-1425	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + SY-1425	DCF5CKV	SY-1425	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + SY-1425	DCL69GJ	SY-1425	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + SY-1425	DCVDJ6Q	SY-1425	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + SY-1425	DCDXUEZ	SY-1425	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + SY-1425	DC7P54Z	SY-1425	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + SY-1425	DC5UWNF	SY-1425	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + SY-1425	DCSJYHZ	SY-1425	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + SY-1425	DCUYL3N	SY-1425	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + SY-1425	DC3JC4U	SY-1425	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + SY-1425	DC3HIHL	SY-1425	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + SY-1425	DCD82CM	SY-1425	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + SY-1425	DCK05N1	SY-1425	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + SY-1425	DC8AXGT	SY-1425	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + SY-1425	DCLT4H1	SY-1425	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + SY-1425	DCQS69I	SY-1425	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + SY-1425	DC0EZ50	SY-1425	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + SY-1425	DC8VA2B	SY-1425	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + SY-1425	DC4IIU3	SY-1425	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Uracil mustard	DC92Z5J	Uracil mustard	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Uracil mustard	DCFR5BZ	Uracil mustard	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Uracil mustard	DCR3D0Y	Uracil mustard	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Uracil mustard	DCFN6DO	Uracil mustard	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Uracil mustard	DC9I1D2	Uracil mustard	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Uracil mustard	DCOGUGZ	Uracil mustard	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Uracil mustard	DCHD984	Uracil mustard	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Uracil mustard	DC0IYWJ	Uracil mustard	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Uracil mustard	DCZX6JK	Uracil mustard	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Uracil mustard	DCA2Y1M	Uracil mustard	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Uracil mustard	DCU2BY5	Uracil mustard	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Uracil mustard	DCJG7W0	Uracil mustard	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Uracil mustard	DCB031S	Uracil mustard	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Uracil mustard	DC4Q36A	Uracil mustard	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Uracil mustard	DCD68U0	Uracil mustard	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Uracil mustard	DC6WSFQ	Uracil mustard	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Uracil mustard	DC4UFKO	Uracil mustard	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Uracil mustard	DCK73HK	Uracil mustard	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Uracil mustard	DCA3GKP	Uracil mustard	Melanoma (Cell Line: SK-MEL-2)	[3]
Cabazitaxel + Uracil mustard	DCDTEVZ	Uracil mustard	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Uracil mustard	DCG5LSJ	Uracil mustard	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Uracil mustard	DCSDUI4	Uracil mustard	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Uracil mustard	DCRR3BY	Uracil mustard	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Uracil mustard	DC8MI7J	Uracil mustard	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Uracil mustard	DCMUCUX	Uracil mustard	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Vincristine	DC0X5FB	Vincristine	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Vincristine	DCHR3JP	Vincristine	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Vincristine	DCWN328	Vincristine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Vincristine	DCRT3BG	Vincristine	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Vincristine	DCV5J7A	Vincristine	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Vincristine	DCLJSXB	Vincristine	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Vincristine	DCT8VKH	Vincristine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Vincristine	DCKJ4NN	Vincristine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Vincristine	DC35GTA	Vincristine	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Vincristine	DCCZ7OK	Vincristine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Vincristine	DC6FJ7Q	Vincristine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Vincristine	DCM8W84	Vincristine	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Vincristine	DCNP0PM	Vincristine	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Vincristine	DC9ZEF7	Vincristine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Vincristine	DCC7BHU	Vincristine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Vincristine	DCAT2EX	Vincristine	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Vincristine	DCVX2JS	Vincristine	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Vincristine	DCFQXR9	Vincristine	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Vincristine	DCR36OI	Vincristine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Vincristine	DCREWE5	Vincristine	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Vincristine	DCP63RT	Vincristine	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Vincristine	DCPGT88	Vincristine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Arfolitixorin	DC7QMIR	Arfolitixorin	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Arfolitixorin	DCKV0ZY	Arfolitixorin	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Arfolitixorin	DCT7VGF	Arfolitixorin	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Arfolitixorin	DCUI8FE	Arfolitixorin	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Arfolitixorin	DCH1I66	Arfolitixorin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Arfolitixorin	DCTDRW1	Arfolitixorin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Arfolitixorin	DCPTLUM	Arfolitixorin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Arfolitixorin	DC4XSF9	Arfolitixorin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Arfolitixorin	DC249F9	Arfolitixorin	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Arfolitixorin	DCO9BB9	Arfolitixorin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Arfolitixorin	DCJHVPQ	Arfolitixorin	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Arfolitixorin	DC8T5SS	Arfolitixorin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Arfolitixorin	DCB25EK	Arfolitixorin	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Arfolitixorin	DCW59RR	Arfolitixorin	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Arfolitixorin	DCR574I	Arfolitixorin	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + BIO-300	DCDNN52	BIO-300	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + BIO-300	DCQV82G	BIO-300	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + BIO-300	DC1HKCV	BIO-300	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + BIO-300	DCHIS3E	BIO-300	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + BIO-300	DCQLZ5V	BIO-300	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + BIO-300	DCLA0DV	BIO-300	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + BIO-300	DCU2NWH	BIO-300	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + BIO-300	DCMA8A0	BIO-300	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + BIO-300	DCDJYHB	BIO-300	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + BIO-300	DCDJX8Y	BIO-300	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + BIO-300	DC9ASEF	BIO-300	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + BIO-300	DC9OHKE	BIO-300	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + BIO-300	DC2CJHQ	BIO-300	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + BIO-300	DCDJL2T	BIO-300	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + BIO-300	DCON9OV	BIO-300	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + BIO-300	DC2QQQV	BIO-300	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + BIO-300	DC5913L	BIO-300	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + BIO-300	DCPGGX9	BIO-300	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + BIO-300	DCX9UIH	BIO-300	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + BIO-300	DCE5X1J	BIO-300	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Altretamine	DC4VQHH	Altretamine	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Altretamine	DCMXUMT	Altretamine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Altretamine	DCFK40D	Altretamine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Altretamine	DC41K76	Altretamine	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Altretamine	DCVYGMK	Altretamine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + TEM	DCJTBVH	TEM	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + JNK-IN-8	DCSJYRS	JNK-IN-8	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + JNK-IN-8	DCNXMJU	JNK-IN-8	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + JNK-IN-8	DC5AFQ5	JNK-IN-8	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + JNK-IN-8	DCJH2E0	JNK-IN-8	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + JNK-IN-8	DC3NKY4	JNK-IN-8	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + JNK-IN-8	DCUZ6F8	JNK-IN-8	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + JNK-IN-8	DC72DKY	JNK-IN-8	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + JNK-IN-8	DCN7O8T	JNK-IN-8	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + JNK-IN-8	DC61GXS	JNK-IN-8	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + JNK-IN-8	DCSRSU9	JNK-IN-8	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + JNK-IN-8	DC9M25H	JNK-IN-8	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + JNK-IN-8	DCOIQA9	JNK-IN-8	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + JNK-IN-8	DC84H27	JNK-IN-8	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + JNK-IN-8	DCF7B7I	JNK-IN-8	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + JNK-IN-8	DCD5CIT	JNK-IN-8	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + JNK-IN-8	DCSQEOL	JNK-IN-8	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + JNK-IN-8	DCP3KRB	JNK-IN-8	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + JNK-IN-8	DC3SF5P	JNK-IN-8	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Idarubicin	DC9PUJM	Idarubicin	Glioblastoma? (Cell Line: T98G)	[3]
Cabazitaxel + Idarubicin	DCSTWJ9	Idarubicin	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Idarubicin	DC2X9ZS	Idarubicin	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Indazole derivative 5	DC1EEQD	Indazole derivative 5	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Indazole derivative 5	DCSUMFP	Indazole derivative 5	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Indazole derivative 5	DC6DFCH	Indazole derivative 5	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Indazole derivative 5	DCBOHYL	Indazole derivative 5	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Indazole derivative 5	DC3TUPD	Indazole derivative 5	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Indazole derivative 5	DCDOMVJ	Indazole derivative 5	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Indazole derivative 5	DCQPLEC	Indazole derivative 5	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Imatinib	DC19EMB	Imatinib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Imatinib	DCI21S6	Imatinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Imatinib	DC65D0X	Imatinib	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Imatinib	DCMS93T	Imatinib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Bleomycin	DC2EBHQ	Bleomycin	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Bleomycin	DCNY6UL	Bleomycin	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Bleomycin	DC0AXJX	Bleomycin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Bleomycin	DCK0ODQ	Bleomycin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Bleomycin	DCC69VH	Bleomycin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Bleomycin	DC440A8	Bleomycin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Bleomycin	DC5ZSOA	Bleomycin	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Bleomycin	DCNWSRB	Bleomycin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Bleomycin	DCR346H	Bleomycin	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Bleomycin	DC80NU3	Bleomycin	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Bleomycin	DCGWP4Q	Bleomycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Bleomycin	DCIG22T	Bleomycin	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Bleomycin	DCHWI12	Bleomycin	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Bleomycin	DCDVSR9	Bleomycin	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Bleomycin	DCXZSMZ	Bleomycin	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Bleomycin	DCYQKZV	Bleomycin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Bleomycin	DCVMNBG	Bleomycin	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Bleomycin	DC3G0K1	Bleomycin	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Bortezomib	DCO8EJ4	Bortezomib	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Bortezomib	DCW9WSH	Bortezomib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Bortezomib	DCKS2LD	Bortezomib	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Bortezomib	DCKL8CZ	Bortezomib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Bortezomib	DCPMK2F	Bortezomib	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Bortezomib	DCM95NA	Bortezomib	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Bortezomib	DCCTSRL	Bortezomib	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Bortezomib	DC9UF4K	Bortezomib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Bortezomib	DC74QA3	Bortezomib	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Bortezomib	DC1YKX4	Bortezomib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Bortezomib	DCA7W4D	Bortezomib	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Bortezomib	DCLCRC4	Bortezomib	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Bortezomib	DC3JDP9	Bortezomib	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Bortezomib	DCKYI5X	Bortezomib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Bortezomib	DCX2AFJ	Bortezomib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Bortezomib	DCCCKE5	Bortezomib	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Bortezomib	DC0RFJ4	Bortezomib	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Anastrozole	DC7SNW1	Anastrozole	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Anastrozole	DCDDIOA	Anastrozole	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Anastrozole	DCCDYCA	Anastrozole	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Anastrozole	DCS7ILA	Anastrozole	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Anastrozole	DCTVF9E	Anastrozole	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Anastrozole	DC7AE5Q	Anastrozole	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Anastrozole	DCIV2GJ	Anastrozole	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Anastrozole	DCTLWBC	Anastrozole	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Anastrozole	DCWFOHV	Anastrozole	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Anastrozole	DC5UWSG	Anastrozole	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Anastrozole	DCADGPM	Anastrozole	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Anastrozole	DC2WNIY	Anastrozole	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Anastrozole	DCDIB54	Anastrozole	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Anastrozole	DC7XU6O	Anastrozole	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Anastrozole	DCLQMQB	Anastrozole	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Anastrozole	DC3ERWU	Anastrozole	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Anastrozole	DCM4ZUU	Anastrozole	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Anastrozole	DCUFCJQ	Anastrozole	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Anastrozole	DCMZAP2	Anastrozole	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Dacarbazine	DCXGTCW	Dacarbazine	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Dacarbazine	DC2S3IK	Dacarbazine	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Dacarbazine	DCJYYSM	Dacarbazine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Dacarbazine	DCTRNQX	Dacarbazine	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Dacarbazine	DCM6OFW	Dacarbazine	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Dacarbazine	DCNP7RV	Dacarbazine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Dacarbazine	DCR5F7O	Dacarbazine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Dacarbazine	DCGBTQP	Dacarbazine	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Dacarbazine	DC417S5	Dacarbazine	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Dacarbazine	DCYUI6W	Dacarbazine	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Dacarbazine	DC6XWML	Dacarbazine	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Dacarbazine	DCQB8ZJ	Dacarbazine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Dacarbazine	DCOUMMF	Dacarbazine	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Dacarbazine	DCLIR66	Dacarbazine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Dacarbazine	DC44XUQ	Dacarbazine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Dacarbazine	DCQGC8I	Dacarbazine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Dacarbazine	DCM1NKR	Dacarbazine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Dacarbazine	DCEN4IC	Dacarbazine	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Dacarbazine	DC1UO6U	Dacarbazine	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Dacarbazine	DC8JHPS	Dacarbazine	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Dacarbazine	DC69K05	Dacarbazine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Dacarbazine	DCB02QZ	Dacarbazine	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Dacarbazine	DC2DRC2	Dacarbazine	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Dacarbazine	DC1AUE3	Dacarbazine	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Dacarbazine	DCKC144	Dacarbazine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Valrubicin	DCNA33S	Valrubicin	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Valrubicin	DCBEPLK	Valrubicin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Valrubicin	DCEMB0C	Valrubicin	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Valrubicin	DCMI9BV	Valrubicin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Valrubicin	DCC646R	Valrubicin	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Valrubicin	DCOL9W3	Valrubicin	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Valrubicin	DCY9GT6	Valrubicin	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Valrubicin	DCW3PP9	Valrubicin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Valrubicin	DCLSBE0	Valrubicin	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Valrubicin	DCO3M3B	Valrubicin	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Valrubicin	DCETQD7	Valrubicin	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Valrubicin	DCW1QAY	Valrubicin	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Topotecan	DC9XCTQ	Topotecan	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Topotecan	DC733ZB	Topotecan	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Topotecan	DCPQSNT	Topotecan	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Topotecan	DC77QJB	Topotecan	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Topotecan	DCLPKXU	Topotecan	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Topotecan	DCJV2VM	Topotecan	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Topotecan	DCP76E4	Topotecan	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Topotecan	DCGPTS1	Topotecan	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Topotecan	DC2KM9B	Topotecan	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Topotecan	DCU7BHZ	Topotecan	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Topotecan	DCDBBC9	Topotecan	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Topotecan	DCPYWZS	Topotecan	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Topotecan	DC8SDK5	Topotecan	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Topotecan	DCST11K	Topotecan	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Topotecan	DCPI208	Topotecan	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Topotecan	DC7FVCZ	Topotecan	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Topotecan	DC3GZX5	Topotecan	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Cisplatin	DCLATA3	Cisplatin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Cisplatin	DCEBTO2	Cisplatin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Vandetanib	DCZV0RR	Vandetanib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Vandetanib	DCNC3SP	Vandetanib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Vandetanib	DCYAJTA	Vandetanib	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Vandetanib	DCA098B	Vandetanib	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Vandetanib	DC3JOK7	Vandetanib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Vandetanib	DCKCXZR	Vandetanib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Vandetanib	DCUEWSM	Vandetanib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Vandetanib	DCZLW10	Vandetanib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Cabazitaxel + Vandetanib	DCGLL48	Vandetanib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Vandetanib	DCKJTAO	Vandetanib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Vandetanib	DCYGJ0B	Vandetanib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Vandetanib	DCEPSIO	Vandetanib	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Vandetanib	DCBQQVP	Vandetanib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Vandetanib	DCOXC4I	Vandetanib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Chlorambucil	DCZ4MAF	Chlorambucil	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Chlorambucil	DCJ85Q0	Chlorambucil	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Chlorambucil	DCGXB00	Chlorambucil	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Chlorambucil	DCQQKZY	Chlorambucil	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Chlorambucil	DCM5OYH	Chlorambucil	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Chlorambucil	DCIPKWS	Chlorambucil	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Chlorambucil	DC3IRP0	Chlorambucil	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Chlorambucil	DCYL3S0	Chlorambucil	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Chlorambucil	DCXYHE2	Chlorambucil	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Chlorambucil	DCMHNC7	Chlorambucil	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Chlorambucil	DCD71KK	Chlorambucil	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Chlorambucil	DCAWV7O	Chlorambucil	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Chlorambucil	DCD9AFB	Chlorambucil	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Chlorambucil	DC2X3QA	Chlorambucil	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Chlorambucil	DCRN59A	Chlorambucil	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Sorafenib	DCQP5SK	Sorafenib	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Sorafenib	DCQJ5AA	Sorafenib	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Sorafenib	DCNFQU8	Sorafenib	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Sorafenib	DCZC7EZ	Sorafenib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Sorafenib	DCQPRVQ	Sorafenib	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Sorafenib	DC4DX0U	Sorafenib	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Sorafenib	DCEOXW7	Sorafenib	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Sorafenib	DCOQT5K	Sorafenib	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Sorafenib	DC1ZK0O	Sorafenib	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Sorafenib	DCPVBSJ	Sorafenib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Sorafenib	DCTFCOE	Sorafenib	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + Sorafenib	DCZU6X0	Sorafenib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Sorafenib	DC7XRCZ	Sorafenib	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Sorafenib	DCV2AQD	Sorafenib	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Sorafenib	DCHPFIR	Sorafenib	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Sorafenib	DCQ4NSX	Sorafenib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Sorafenib	DCXA4PM	Sorafenib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Sorafenib	DCTEU0Y	Sorafenib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Sorafenib	DCZ3YNB	Sorafenib	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Sorafenib	DC85T2R	Sorafenib	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Sorafenib	DCH9MFB	Sorafenib	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Sorafenib	DCFHC83	Sorafenib	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Sorafenib	DCI4ZCU	Sorafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Sorafenib	DCHR8XA	Sorafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Sorafenib	DC2LX1O	Sorafenib	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Sorafenib	DCR0OZP	Sorafenib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Sorafenib	DCMSSTV	Sorafenib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Sorafenib	DCOP0TA	Sorafenib	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Sorafenib	DCVYSFI	Sorafenib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Sorafenib	DC7U0UR	Sorafenib	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Sorafenib	DC7ASRW	Sorafenib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Sorafenib	DCURIWQ	Sorafenib	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + ER819762	DC1BA35	ER819762	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Romidepsin	DC5BINF	Romidepsin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Romidepsin	DC8SDAG	Romidepsin	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Romidepsin	DC1ZBIS	Romidepsin	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Romidepsin	DCU1T2L	Romidepsin	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Romidepsin	DC6DW7I	Romidepsin	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Romidepsin	DCUMGKX	Romidepsin	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Cabazitaxel + Romidepsin	DC7NK7R	Romidepsin	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + Romidepsin	DCQDAMB	Romidepsin	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Romidepsin	DC0IYBW	Romidepsin	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Azacitidine	DC63DU3	Azacitidine	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Azacitidine	DCFHJ83	Azacitidine	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Azacitidine	DCCFR9O	Azacitidine	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Azacitidine	DCUGLYX	Azacitidine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Azacitidine	DCERVDY	Azacitidine	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Azacitidine	DCY5III	Azacitidine	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Azacitidine	DCIIW1V	Azacitidine	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Azacitidine	DCGUSQ0	Azacitidine	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Azacitidine	DC8605A	Azacitidine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Azacitidine	DCKMR3Y	Azacitidine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Azacitidine	DCOOVPT	Azacitidine	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Azacitidine	DCQPUEH	Azacitidine	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Azacitidine	DCGI3EN	Azacitidine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Azacitidine	DCHCJ6A	Azacitidine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Azacitidine	DCREI8R	Azacitidine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Azacitidine	DCQ32W6	Azacitidine	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Azacitidine	DCOT0GT	Azacitidine	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Azacitidine	DCMH380	Azacitidine	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Azacitidine	DCDWZ2M	Azacitidine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Azacitidine	DCT49HG	Azacitidine	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Azacitidine	DCOBJTF	Azacitidine	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Azacitidine	DCCKODX	Azacitidine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Azacitidine	DC7UAJB	Azacitidine	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Pomalidomide	DCETYZZ	Pomalidomide	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Vinflunine	DCJ5Z1K	Vinflunine	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Vinflunine	DCIZWS0	Vinflunine	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Cabazitaxel + Vinflunine	DC8XHIC	Vinflunine	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + Vinflunine	DC4H26Y	Vinflunine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Vinflunine	DC32MB5	Vinflunine	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Vinflunine	DCJA90T	Vinflunine	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Vinflunine	DCX39YP	Vinflunine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Vinflunine	DCT07QU	Vinflunine	Glioblastoma (Cell Line: SNB-75)	[3]
Cabazitaxel + Vinflunine	DC3YUB8	Vinflunine	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Vinflunine	DCHIAAZ	Vinflunine	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Vinflunine	DCISXGO	Vinflunine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + Vinflunine	DC1VTQ8	Vinflunine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Vinflunine	DC9NVC6	Vinflunine	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Vinflunine	DCNJCTT	Vinflunine	Melanoma (Cell Line: SK-MEL-2)	[3]
Cabazitaxel + Vinflunine	DC39CLN	Vinflunine	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Vinflunine	DCIO655	Vinflunine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Mercaptopurine	DCDVBEU	Mercaptopurine	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Mercaptopurine	DCRH15E	Mercaptopurine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Mercaptopurine	DCNMWM5	Mercaptopurine	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Mercaptopurine	DCQEY27	Mercaptopurine	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Mercaptopurine	DCB4MT3	Mercaptopurine	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Mercaptopurine	DCB3TXQ	Mercaptopurine	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Mepacrine	DCQ7M2B	Mepacrine	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + Mepacrine	DCDJ0HN	Mepacrine	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Mepacrine	DC10HZE	Mepacrine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Mepacrine	DCIPX8T	Mepacrine	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Mepacrine	DCH4KJG	Mepacrine	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Mepacrine	DC48R0D	Mepacrine	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Mepacrine	DCURPV7	Mepacrine	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Taxol	DC7A0VU	Taxol	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Taxol	DCN2YLS	Taxol	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + Taxol	DCDN3AY	Taxol	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Taxol	DC9YC2R	Taxol	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Taxol	DCZKB1U	Taxol	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Taxol	DCC35YQ	Taxol	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Taxol	DCA7QKW	Taxol	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Taxol	DCQLY2Z	Taxol	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Taxol	DC6EILQ	Taxol	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Taxol	DCVGJUQ	Taxol	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Taxol	DCWDW2Q	Taxol	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Taxol	DC9XKWP	Taxol	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Taxol	DC6YHW8	Taxol	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Taxol	DC0EFYW	Taxol	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Taxol	DCO0RUF	Taxol	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Taxol	DCDLOIO	Taxol	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Taxol	DCACEGM	Taxol	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Taxol	DCO5OWV	Taxol	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Cabazitaxel + Taxol	DCEXYHR	Taxol	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Taxol	DCO0VXH	Taxol	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Taxol	DCZ0FKH	Taxol	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Taxol	DCHZH8U	Taxol	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + Taxol	DC5D0RI	Taxol	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Taxol	DCNCX28	Taxol	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Taxol	DCJQUQ1	Taxol	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Taxol	DCNJEWA	Taxol	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Taxol	DC5PWQP	Taxol	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Taxol	DC2BZCV	Taxol	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Taxol	DCPHLFE	Taxol	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Fludarabine	DCXNZ0K	Fludarabine	Amelanotic melanoma (Cell Line: M14)	[3]
Cabazitaxel + Fludarabine	DCCT8L9	Fludarabine	Astrocytoma (Cell Line: SNB-19)	[3]
Cabazitaxel + Fludarabine	DC2Z0RR	Fludarabine	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Fludarabine	DC9EWEN	Fludarabine	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Fludarabine	DC8KAGP	Fludarabine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Fludarabine	DCSXSIU	Fludarabine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Cabazitaxel + Fludarabine	DC1ZIXJ	Fludarabine	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Fludarabine	DCV8N02	Fludarabine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Cabazitaxel + Fludarabine	DCHVUP1	Fludarabine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Cabazitaxel + PMID28870136-Compound-43	DC33GHJ	PMID28870136-Compound-43	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Cabazitaxel + PMID28870136-Compound-43	DCW0ECT	PMID28870136-Compound-43	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + PMID28870136-Compound-43	DC54XH5	PMID28870136-Compound-43	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + FORMESTANE	DCPTE6O	FORMESTANE	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + FORMESTANE	DCXLKWU	FORMESTANE	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + FORMESTANE	DC51DHZ	FORMESTANE	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Aminolevulinic Acid Hydrochloride	DCPX0MS	Aminolevulinic Acid Hydrochloride	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Aminolevulinic Acid Hydrochloride	DCA4TIZ	Aminolevulinic Acid Hydrochloride	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Estramustine	DC1AXBJ	Estramustine	Adenocarcinoma (Cell Line: DU-145)	[3]
Cabazitaxel + Estramustine	DCBAZBE	Estramustine	Adenocarcinoma (Cell Line: A549)	[3]
Cabazitaxel + Estramustine	DC4EB3E	Estramustine	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Estramustine	DC4IPS9	Estramustine	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Estramustine	DCCZXCR	Estramustine	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Estramustine	DC3YZ3T	Estramustine	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Estramustine	DC86NJ2	Estramustine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Estramustine	DCUT1KH	Estramustine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Estramustine	DCF9765	Estramustine	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Estramustine	DC6DV3I	Estramustine	Astrocytoma (Cell Line: U251)	[3]
Cabazitaxel + Estramustine	DCNZNXL	Estramustine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Cabazitaxel + Estramustine	DCO913O	Estramustine	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Estramustine	DCW4JX3	Estramustine	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Estramustine	DCVKE8S	Estramustine	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Cabazitaxel + Estramustine	DCQBVFJ	Estramustine	Glioma (Cell Line: SF-539)	[3]
Cabazitaxel + Estramustine	DCNP2JC	Estramustine	Glioma (Cell Line: SF-295)	[3]
Cabazitaxel + Estramustine	DCWAMGC	Estramustine	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Cabazitaxel + Estramustine	DCWDWAO	Estramustine	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Estramustine	DCCETUR	Estramustine	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Estramustine	DCW7XPF	Estramustine	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Estramustine	DCPSGGQ	Estramustine	Melanoma (Cell Line: UACC-257)	[3]
Cabazitaxel + Estramustine	DCU9C20	Estramustine	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[3]
Cabazitaxel + Estramustine	DCS45O5	Estramustine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Cabazitaxel + Estramustine	DCLL8BU	Estramustine	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Estramustine	DC3VZHC	Estramustine	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Cabazitaxel + Estramustine	DCQWLDO	Estramustine	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Estramustine	DCXY7M1	Estramustine	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Digitoxin	DC72SEL	Digitoxin	Adenocarcinoma (Cell Line: HT29)	[3]
Cabazitaxel + Digitoxin	DCAZH9E	Digitoxin	Adenocarcinoma (Cell Line: HCT116)	[3]
Cabazitaxel + Digitoxin	DCE1VZ5	Digitoxin	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Cabazitaxel + Digitoxin	DCOZX4K	Digitoxin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Cabazitaxel + Digitoxin	DCTQ49D	Digitoxin	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Cabazitaxel + Digitoxin	DCXBWY7	Digitoxin	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[3]
Cabazitaxel + Digitoxin	DCG3EXU	Digitoxin	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Cabazitaxel + Digitoxin	DC22EZS	Digitoxin	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
Cabazitaxel + Digitoxin	DCFLU7A	Digitoxin	Clear cell renal cell carcinoma (Cell Line: A498)	[3]
Cabazitaxel + Digitoxin	DCB425F	Digitoxin	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Cabazitaxel + Digitoxin	DCHKX4W	Digitoxin	Malignant melanoma (Cell Line: UACC62)	[3]
Cabazitaxel + Digitoxin	DC2R6KA	Digitoxin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Digitoxin	DC4NQ9R	Digitoxin	Prostate carcinoma (Cell Line: PC-3)	[3]
Cabazitaxel + Digitoxin	DCCI6IA	Digitoxin	Renal cell carcinoma (Cell Line: SN12C)	[3]
Cabazitaxel + Dasatinib	DC7HDLB	Dasatinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Cabazitaxel + Dasatinib	DCFJ2GE	Dasatinib	Adenocarcinoma (Cell Line: SW-620)	[3]
Cabazitaxel + Dasatinib	DCZ6N1D	Dasatinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Cabazitaxel + Dasatinib	DC74QVK	Dasatinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Cabazitaxel + Dasatinib	DC8FY2D	Dasatinib	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Cabazitaxel + Dasatinib	DCQ7S2I	Dasatinib	Glioma (Cell Line: SF-268)	[3]
Cabazitaxel + Dasatinib	DCFGUCB	Dasatinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Cabazitaxel + Dasatinib	DCJC3JS	Dasatinib	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
Cabazitaxel + Dasatinib	DCOXT3V	Dasatinib	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Cabazitaxel + Dasatinib	DCKAL2E	Dasatinib	Melanoma (Cell Line: MALME-3M)	[3]
Cabazitaxel + Dasatinib	DCHDUIK	Dasatinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Dasatinib	DCU7FYX	Dasatinib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[3]
Cabazitaxel + Dasatinib	DCYN7AK	Dasatinib	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Cabazitaxel + Dasatinib	DC9D4AD	Dasatinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Cabazitaxel + Dasatinib	DC0WDTN	Dasatinib	Renal cell carcinoma (Cell Line: UO-31)	[3]
Cabazitaxel + Pentostatin	DC7EWFK	Pentostatin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Pentostatin	DCEPTJR	Pentostatin	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Fulvestrant	DCO9WU0	Fulvestrant	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Fulvestrant	DCKJ9N4	Fulvestrant	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Gefitinib	DCCKGYI	Gefitinib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Gefitinib	DCM5AKC	Gefitinib	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Gefitinib	DC1VYTV	Gefitinib	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Gefitinib	DCI9ZMO	Gefitinib	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Gefitinib	DC13P7Y	Gefitinib	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Gefitinib	DC8MW52	Gefitinib	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Ruxolitinib	DCHP5JF	Ruxolitinib	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Hepzato	DCMZ1AM	Hepzato	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Ixabepilone	DCWFABA	Ixabepilone	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Ixabepilone	DC53UXQ	Ixabepilone	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Dactinomycin	DCV6FZ4	Dactinomycin	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Dactinomycin	DC2A9CL	Dactinomycin	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Dactinomycin	DCE578J	Dactinomycin	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Dactinomycin	DC5MO95	Dactinomycin	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + DFN-15	DCB6CNG	DFN-15	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Lapatinib	DC114U1	Lapatinib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + PMID28460551-Compound-2	DCXAW0T	PMID28460551-Compound-2	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + PMID28460551-Compound-2	DCU4EQ8	PMID28460551-Compound-2	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + PMID28460551-Compound-2	DCDWWHY	PMID28460551-Compound-2	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Vismodegib	DCF8CFD	Vismodegib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Vismodegib	DC3F1FG	Vismodegib	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Lenalidomide	DCPZ4RQ	Lenalidomide	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Plicamycin	DCBLV1H	Plicamycin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Plicamycin	DCASK5E	Plicamycin	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Plicamycin	DC7Z603	Plicamycin	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Plicamycin	DCI8H5T	Plicamycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Plicamycin	DCBZD4E	Plicamycin	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Triapine	DC9S5AU	Triapine	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + ABIRATERONE	DCA3ZES	ABIRATERONE	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + ABIRATERONE	DCN7AIM	ABIRATERONE	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + 10-hydroxycamptothecin	DCKWBQO	10-hydroxycamptothecin	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Topetecan	DC6F6LJ	Topetecan	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Topetecan	DCFF6C7	Topetecan	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Pralatrexate	DCJDBPA	Pralatrexate	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Pralatrexate	DC9PHCA	Pralatrexate	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Pralatrexate	DCDEG3C	Pralatrexate	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Pralatrexate	DCSWP76	Pralatrexate	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Terameprocol	DCBXQQZ	Terameprocol	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Dexrazoxane	DC1W9N0	Dexrazoxane	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Dexrazoxane	DCYCZUN	Dexrazoxane	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Docetaxel	DCZQUB4	Docetaxel	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Docetaxel	DCQBZD2	Docetaxel	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Docetaxel	DCQIW03	Docetaxel	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Docetaxel	DC0L0N5	Docetaxel	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Raloxifene	DCAT126	Raloxifene	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Raloxifene	DC69HUX	Raloxifene	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Raloxifene	DCT9NSF	Raloxifene	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Raloxifene	DCBKX6X	Raloxifene	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Bendamustine hydrochloride	DCWMHN9	Bendamustine hydrochloride	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Bendamustine hydrochloride	DC8WTQV	Bendamustine hydrochloride	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Trifluridine	DC6NGHG	Trifluridine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Trifluridine	DC2G4L9	Trifluridine	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Trifluridine	DCJJI40	Trifluridine	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Trifluridine	DC4JTYP	Trifluridine	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Trifluridine	DCLRIBS	Trifluridine	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Sirolimus	DCVHIHW	Sirolimus	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Sirolimus	DC2XSNE	Sirolimus	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Sirolimus	DC3JVOI	Sirolimus	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Sirolimus	DCLAXWG	Sirolimus	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Sirolimus	DC8WSO3	Sirolimus	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Sirolimus	DCSWP21	Sirolimus	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Sirolimus	DCITP4O	Sirolimus	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Mitomycin	DC0Z46Q	Mitomycin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + SY-1425	DCBKMGH	SY-1425	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + SY-1425	DCEOQSM	SY-1425	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + SY-1425	DCBG3DV	SY-1425	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + SY-1425	DC7KOX2	SY-1425	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + SY-1425	DC5L4VT	SY-1425	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Uracil mustard	DCSQJ6O	Uracil mustard	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Uracil mustard	DCHZFH1	Uracil mustard	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Uracil mustard	DCKVE2U	Uracil mustard	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Uracil mustard	DCY22JJ	Uracil mustard	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Uracil mustard	DC49E4L	Uracil mustard	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Vincristine	DC414L0	Vincristine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Vincristine	DC8MV6Z	Vincristine	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Vincristine	DC84J5F	Vincristine	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Vincristine	DCF7AH2	Vincristine	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Vincristine	DCUVW85	Vincristine	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Arfolitixorin	DC573RM	Arfolitixorin	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + BIO-300	DCOOHUB	BIO-300	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + BIO-300	DCQ1U2D	BIO-300	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Altretamine	DC1YCGE	Altretamine	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Altretamine	DC97TAG	Altretamine	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + TEM	DC7V8Q1	TEM	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + TEM	DC4F0UC	TEM	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + JNK-IN-8	DCMOWN3	JNK-IN-8	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + JNK-IN-8	DC7PUL6	JNK-IN-8	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Bleomycin	DCI2YV5	Bleomycin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Bleomycin	DCT83ME	Bleomycin	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Bleomycin	DCXLQQP	Bleomycin	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Bleomycin	DCX7OK8	Bleomycin	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Bleomycin	DC1H7AD	Bleomycin	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Bortezomib	DC268OW	Bortezomib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Bortezomib	DCD1A38	Bortezomib	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Bortezomib	DC6ZMVS	Bortezomib	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Bortezomib	DC2992E	Bortezomib	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Bortezomib	DCKRR3I	Bortezomib	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Anastrozole	DCU4J9G	Anastrozole	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Anastrozole	DCK9WX7	Anastrozole	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Anastrozole	DC095CB	Anastrozole	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Anastrozole	DC2BU7V	Anastrozole	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Dacarbazine	DCNKRT8	Dacarbazine	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Dacarbazine	DCCJJ4J	Dacarbazine	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Valrubicin	DC5CXAR	Valrubicin	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Valrubicin	DC5PPI8	Valrubicin	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Topotecan	DCYDTDK	Topotecan	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Topotecan	DC3UPMD	Topotecan	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Vandetanib	DCJVPXC	Vandetanib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Chlorambucil	DCWAK7L	Chlorambucil	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Chlorambucil	DCSKFB0	Chlorambucil	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Sorafenib	DC2TTY7	Sorafenib	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Azacitidine	DC4F5N6	Azacitidine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Azacitidine	DC8NF0S	Azacitidine	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Azacitidine	DC783TC	Azacitidine	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Azacitidine	DCT983B	Azacitidine	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Pomalidomide	DCA6B1L	Pomalidomide	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Pomalidomide	DCH0E0R	Pomalidomide	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Vinflunine	DCRFFYI	Vinflunine	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Cabazitaxel + Vinflunine	DCC5HLY	Vinflunine	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Vinflunine	DCRZUEE	Vinflunine	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Mepacrine	DC4J9WV	Mepacrine	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Mepacrine	DCU2SXP	Mepacrine	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Taxol	DCFU6FC	Taxol	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Taxol	DCNMEQ2	Taxol	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Taxol	DCHMBJR	Taxol	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Taxol	DCPPW3P	Taxol	Colon carcinoma (Cell Line: KM12)	[4]
Cabazitaxel + Taxol	DCPT8ZY	Taxol	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Taxol	DCMWD3I	Taxol	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Taxol	DCS3GV7	Taxol	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Fludarabine	DC0DAPH	Fludarabine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + PMID28870136-Compound-43	DCQ1XP7	PMID28870136-Compound-43	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Estramustine	DCX5ASX	Estramustine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Cabazitaxel + Estramustine	DC1STTG	Estramustine	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Estramustine	DCJJYTI	Estramustine	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Estramustine	DCSP3TQ	Estramustine	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Cabazitaxel + Estramustine	DC2BD07	Estramustine	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Cabazitaxel + Estramustine	DCB8VWC	Estramustine	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Cabazitaxel + Digitoxin	DC7SOWI	Digitoxin	Carcinoma (Cell Line: RXF 393)	[4]
Cabazitaxel + Digitoxin	DCY7PWB	Digitoxin	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Crizotinib + Cabazitaxel	DCX7HHI	Crizotinib	Adenocarcinoma (Cell Line: DU-145)	[3]
Crizotinib + Cabazitaxel	DC82TQR	Crizotinib	Adenocarcinoma (Cell Line: A549)	[3]
Crizotinib + Cabazitaxel	DCGSJMY	Crizotinib	Adenocarcinoma (Cell Line: NCIH23)	[3]
Crizotinib + Cabazitaxel	DC9KU1R	Crizotinib	Adenocarcinoma (Cell Line: SW-620)	[3]
Crizotinib + Cabazitaxel	DC4JDXB	Crizotinib	Adenocarcinoma (Cell Line: HT29)	[3]
Crizotinib + Cabazitaxel	DCWNGYZ	Crizotinib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[3]
Crizotinib + Cabazitaxel	DCH7H9H	Crizotinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Crizotinib + Cabazitaxel	DCCZM0M	Crizotinib	Anaplastic large cell lymphoma (Cell Line: SR)	[3]
Crizotinib + Cabazitaxel	DCW68QN	Crizotinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Crizotinib + Cabazitaxel	DC36T66	Crizotinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Crizotinib + Cabazitaxel	DCLC0XH	Crizotinib	Glioma (Cell Line: SF-268)	[3]
Crizotinib + Cabazitaxel	DC2RYQZ	Crizotinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Crizotinib + Cabazitaxel	DC22VFY	Crizotinib	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Crizotinib + Cabazitaxel	DCY5JF7	Crizotinib	Malignant melanoma (Cell Line: UACC62)	[3]
Crizotinib + Cabazitaxel	DCMHBPN	Crizotinib	Melanoma (Cell Line: MALME-3M)	[3]
Crizotinib + Cabazitaxel	DCJ7X3G	Crizotinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Crizotinib + Cabazitaxel	DCQ764G	Crizotinib	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Crizotinib + Cabazitaxel	DC3CFH8	Crizotinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Crizotinib + Cabazitaxel	DCLCKMS	Crizotinib	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Epirubicin + Cabazitaxel	DC5YBE5	Epirubicin	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Epirubicin + Cabazitaxel	DCWH56J	Epirubicin	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Epirubicin + Cabazitaxel	DCLBW0L	Epirubicin	Adenocarcinoma (Cell Line: NCIH23)	[5]
Epirubicin + Cabazitaxel	DCRXC65	Epirubicin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[5]
Epirubicin + Cabazitaxel	DCT4R29	Epirubicin	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[5]
Epirubicin + Cabazitaxel	DC4TLNV	Epirubicin	Lung adenocarcinoma (Cell Line: HOP-62)	[5]
Epirubicin + Cabazitaxel	DC2JSC2	Epirubicin	Melanoma (Cell Line: MALME-3M)	[5]
Epirubicin + Cabazitaxel	DC1CZNP	Epirubicin	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[5]
Indazole derivative 5 + Cabazitaxel	DCREQYB	Indazole derivative 5	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Indazole derivative 5 + Cabazitaxel	DCO9W0V	Indazole derivative 5	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Indazole derivative 5 + Cabazitaxel	DCXYR9G	Indazole derivative 5	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Indazole derivative 5 + Cabazitaxel	DCM887N	Indazole derivative 5	Glioma (Cell Line: SF-268)	[3]
Indazole derivative 5 + Cabazitaxel	DCAJZV9	Indazole derivative 5	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Indazole derivative 5 + Cabazitaxel	DCKHD9I	Indazole derivative 5	Adenocarcinoma (Cell Line: A549)	[5]
Indazole derivative 5 + Cabazitaxel	DC14B5J	Indazole derivative 5	Adenocarcinoma (Cell Line: HCC-2998)	[5]
Indazole derivative 5 + Cabazitaxel	DC0XVOC	Indazole derivative 5	Adenocarcinoma (Cell Line: HCT-15)	[5]
Indazole derivative 5 + Cabazitaxel	DCGIYSY	Indazole derivative 5	Adenocarcinoma (Cell Line: HCT116)	[5]
Indazole derivative 5 + Cabazitaxel	DC23CXH	Indazole derivative 5	Adenocarcinoma (Cell Line: SW-620)	[5]
Indazole derivative 5 + Cabazitaxel	DCIPZ72	Indazole derivative 5	Amelanotic melanoma (Cell Line: MDA-MB-435)	[5]
Indazole derivative 5 + Cabazitaxel	DC8J6XA	Indazole derivative 5	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[5]
Indazole derivative 5 + Cabazitaxel	DCACGL6	Indazole derivative 5	Malignant melanoma (Cell Line: UACC62)	[5]
Indazole derivative 5 + Cabazitaxel	DCT048N	Indazole derivative 5	Melanoma (Cell Line: MALME-3M)	[5]
Raloxifene + Cabazitaxel	DCP10H3	Raloxifene	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Raloxifene + Cabazitaxel	DCGILC1	Raloxifene	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[5]
Ruxolitinib + Cabazitaxel	DCKPPHB	Ruxolitinib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Ruxolitinib + Cabazitaxel	DCU378U	Ruxolitinib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[3]
Ruxolitinib + Cabazitaxel	DC6EGAQ	Ruxolitinib	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Ruxolitinib + Cabazitaxel	DCP9IZW	Ruxolitinib	Carcinoma (Cell Line: MCF7)	[4]
Ruxolitinib + Cabazitaxel	DCSGQ8A	Ruxolitinib	Colon carcinoma (Cell Line: KM12)	[4]
Ruxolitinib + Cabazitaxel	DCVB3IC	Ruxolitinib	Adenocarcinoma (Cell Line: DU-145)	[5]
Ruxolitinib + Cabazitaxel	DC1X4VJ	Ruxolitinib	Adenocarcinoma (Cell Line: A549)	[5]
Ruxolitinib + Cabazitaxel	DCYCGZW	Ruxolitinib	Adenocarcinoma (Cell Line: NCIH23)	[5]
Ruxolitinib + Cabazitaxel	DCN2JM4	Ruxolitinib	Adenocarcinoma (Cell Line: SW-620)	[5]
Ruxolitinib + Cabazitaxel	DC086JL	Ruxolitinib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[5]
Ruxolitinib + Cabazitaxel	DC1TK6P	Ruxolitinib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[5]
Ruxolitinib + Cabazitaxel	DCRQO7V	Ruxolitinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[5]
Vandetanib + Cabazitaxel	DC8W77D	Vandetanib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Vandetanib + Cabazitaxel	DCFE45O	Vandetanib	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Vandetanib + Cabazitaxel	DC0X1R9	Vandetanib	Adenocarcinoma (Cell Line: NCIH23)	[5]
Vandetanib + Cabazitaxel	DC8LN14	Vandetanib	Adenocarcinoma (Cell Line: A549)	[5]
Vandetanib + Cabazitaxel	DCP50GB	Vandetanib	Adenocarcinoma (Cell Line: HT29)	[5]
Vandetanib + Cabazitaxel	DCTQ1TZ	Vandetanib	Adenocarcinoma (Cell Line: HCT-15)	[5]
Vandetanib + Cabazitaxel	DCGC051	Vandetanib	Adenocarcinoma (Cell Line: HCT116)	[5]
Vandetanib + Cabazitaxel	DC3OJJP	Vandetanib	Adenocarcinoma (Cell Line: SW-620)	[5]
Vandetanib + Cabazitaxel	DCAV0YX	Vandetanib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Vandetanib + Cabazitaxel	DCK8K1I	Vandetanib	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Vandetanib + Cabazitaxel	DCT5RJ0	Vandetanib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Vandetanib + Cabazitaxel	DCLM8YQ	Vandetanib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[5]
Vandetanib + Cabazitaxel	DCKLBD0	Vandetanib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[5]
Vandetanib + Cabazitaxel	DCYDPAX	Vandetanib	Lung adenocarcinoma (Cell Line: HOP-62)	[5]
Vandetanib + Cabazitaxel	DCNUFD8	Vandetanib	Lung adenocarcinoma (Cell Line: EKVX)	[5]
Vandetanib + Cabazitaxel	DC0Z95E	Vandetanib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[5]
Vandetanib + Cabazitaxel	DCV68U6	Vandetanib	Melanoma (Cell Line: MALME-3M)	[5]
Vandetanib + Cabazitaxel	DC2F8W2	Vandetanib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[5]
Vandetanib + Cabazitaxel	DCQFZGP	Vandetanib	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
Vandetanib + Cabazitaxel	DCSGTS7	Vandetanib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[5]
Vemurafenib + Cabazitaxel	DCYVVUJ	Vemurafenib	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Vemurafenib + Cabazitaxel	DCUTPGE	Vemurafenib	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Vemurafenib + Cabazitaxel	DCYX3ND	Vemurafenib	Adenocarcinoma (Cell Line: HT29)	[5]
Vemurafenib + Cabazitaxel	DCONBC5	Vemurafenib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[5]
Vemurafenib + Cabazitaxel	DCZ4BW0	Vemurafenib	Amelanotic melanoma (Cell Line: M14)	[5]
Vemurafenib + Cabazitaxel	DCB0MS8	Vemurafenib	Astrocytoma (Cell Line: U251)	[5]
Vemurafenib + Cabazitaxel	DC8LDBT	Vemurafenib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Vemurafenib + Cabazitaxel	DCRTOVS	Vemurafenib	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[5]
Vemurafenib + Cabazitaxel	DC48UHP	Vemurafenib	Cutaneous melanoma (Cell Line: SK-MEL-28)	[5]
Vemurafenib + Cabazitaxel	DCHW3PZ	Vemurafenib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[5]
Vemurafenib + Cabazitaxel	DCTC6C1	Vemurafenib	Melanoma (Cell Line: MALME-3M)	[5]
Vemurafenib + Cabazitaxel	DCI7XQ5	Vemurafenib	Melanoma (Cell Line: UACC-257)	[5]
Vemurafenib + Cabazitaxel	DCKRTC0	Vemurafenib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[5]
Vemurafenib + Cabazitaxel	DCUB5TH	Vemurafenib	Papillary renal cell carcinoma (Cell Line: ACHN)	[5]
Vemurafenib + Cabazitaxel	DCFNBPG	Vemurafenib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[5]
Vemurafenib + Cabazitaxel	DCHPWHI	Vemurafenib	Renal cell carcinoma (Cell Line: UO-31)	[5]
Vismodegib + Cabazitaxel	DC0TA9G	Vismodegib	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Vismodegib + Cabazitaxel	DC4O6V2	Vismodegib	Carcinoma (Cell Line: MCF7)	[4]
Vismodegib + Cabazitaxel	DC8Q18T	Vismodegib	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Vismodegib + Cabazitaxel	DC8HJMD	Vismodegib	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Vismodegib + Cabazitaxel	DCRQROH	Vismodegib	Adenocarcinoma (Cell Line: DU-145)	[5]
Vismodegib + Cabazitaxel	DCFFKW4	Vismodegib	Adenocarcinoma (Cell Line: OVCAR3)	[5]
Vismodegib + Cabazitaxel	DCTWHGN	Vismodegib	Adenocarcinoma (Cell Line: NCIH23)	[5]
Vismodegib + Cabazitaxel	DCYLJFJ	Vismodegib	Adenocarcinoma (Cell Line: A549)	[5]
Vismodegib + Cabazitaxel	DC1PNEM	Vismodegib	Adenocarcinoma (Cell Line: HCT-15)	[5]
Vismodegib + Cabazitaxel	DCJS2E2	Vismodegib	Adenocarcinoma (Cell Line: HCC-2998)	[5]
Vismodegib + Cabazitaxel	DCELR9M	Vismodegib	Adenocarcinoma (Cell Line: HCT116)	[5]
Vismodegib + Cabazitaxel	DCPLLTU	Vismodegib	Adenocarcinoma (Cell Line: HT29)	[5]
Vismodegib + Cabazitaxel	DC1PLQM	Vismodegib	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[5]
Vismodegib + Cabazitaxel	DCGHIOA	Vismodegib	Astrocytoma (Cell Line: U251)	[5]
Vismodegib + Cabazitaxel	DCC2YPB	Vismodegib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[5]
Vismodegib + Cabazitaxel	DC7CSIB	Vismodegib	Chronic myelogenous leukemia (Cell Line: K-562)	[5]
Vismodegib + Cabazitaxel	DC8MTTI	Vismodegib	Clear cell renal cell carcinoma (Cell Line: TK-10)	[5]
Vismodegib + Cabazitaxel	DCABDF7	Vismodegib	Glioma (Cell Line: SF-539)	[5]
Vismodegib + Cabazitaxel	DCSN2RP	Vismodegib	Glioma (Cell Line: SF-295)	[5]
Vismodegib + Cabazitaxel	DCFEOLK	Vismodegib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[5]
Vismodegib + Cabazitaxel	DC4GI6Z	Vismodegib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[5]
Vismodegib + Cabazitaxel	DCRZWSL	Vismodegib	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[5]
Vismodegib + Cabazitaxel	DCYA89K	Vismodegib	Large cell lung carcinoma (Cell Line: NCI-H460)	[5]
Vismodegib + Cabazitaxel	DCWQ3IU	Vismodegib	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[5]
Vismodegib + Cabazitaxel	DCSPK1S	Vismodegib	Lung adenocarcinoma (Cell Line: EKVX)	[5]
Vismodegib + Cabazitaxel	DCUSMF0	Vismodegib	Lung adenocarcinoma (Cell Line: HOP-62)	[5]
Vismodegib + Cabazitaxel	DCX601H	Vismodegib	Lung adenocarcinoma (Cell Line: NCI-H522)	[5]
Vismodegib + Cabazitaxel	DCWM7EB	Vismodegib	Malignant melanoma (Cell Line: UACC62)	[5]
Vismodegib + Cabazitaxel	DCQU74P	Vismodegib	Melanoma (Cell Line: MALME-3M)	[5]
Vismodegib + Cabazitaxel	DCX8XBY	Vismodegib	Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)	[5]
Vismodegib + Cabazitaxel	DCA2CJA	Vismodegib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[5]
Vismodegib + Cabazitaxel	DC7GVQ9	Vismodegib	Non-small cell lung carcinoma (Cell Line: HOP-92)	[5]
Vismodegib + Cabazitaxel	DCSCQXJ	Vismodegib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[5]
Vismodegib + Cabazitaxel	DCP2XU8	Vismodegib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[5]
Vismodegib + Cabazitaxel	DC0Z8ZQ	Vismodegib	Prostate carcinoma (Cell Line: PC-3)	[5]

6 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Cabazitaxel + Prednisolone	DC2PSQP	Prednisolone	Prostate Cancer	[6]
Clarithromycin + Cabazitaxel	DCOAWM2	Clarithromycin	Prostate Cancer	[7]
Gemcitabine + Cabazitaxel	DCLTKD0	Gemcitabine	Neoplasms, Malignant	[8]
Cabazitaxel + Prednisone	DCYV9OC	Prednisone	Hormone-Resistant Prostate Cancer	[9]
Docetaxel + Cabazitaxel	DCS38PC	Docetaxel	Prostate Carcinoma	[10]
Lapatinib + Cabazitaxel	DCHO9NG	Lapatinib	Metastatic Breast Cancer With Intracranial Metastases	[11]

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6798).
• [2] Cabazitaxel FDA Label
• [3] Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
• [4] Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
• [5] Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
• [6] ClinicalTrials.gov (NCT01324583) Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer
• [7] ClinicalTrials.gov (NCT03043989) Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin
• [8] ClinicalTrials.gov (NCT01001221) Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor
• [9] ClinicalTrials.gov (NCT02844582) Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
• [10] ClinicalTrials.gov (NCT03101046) Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic
• [11] ClinicalTrials.gov (NCT01934894) Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases